ENDOMETRIAL UNDIFFERENTIATED CARCINOMA
Clinical trials for ENDOMETRIAL UNDIFFERENTIATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL UNDIFFERENTIATED CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL UNDIFFERENTIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktails aim to stall endometrial Cancer's return
Disease control OngoingThis study tests several drug combinations in women whose endometrial cancer has returned or not responded to treatment. The goal is to see if these combinations can slow or stop cancer growth better than current options. About 288 women are taking part, receiving different drugs…
Matched conditions: ENDOMETRIAL UNDIFFERENTIATED CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Immunotherapy plus chemo shows promise for tough endometrial cancers
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (paclitaxel and carboplatin) helps people with advanced or recurrent endometrial cancer live longer without the cancer growing. About 813 participants with stage III, IV, or recurrent di…
Matched conditions: ENDOMETRIAL UNDIFFERENTIATED CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 05, 2026 11:54 UTC